Physician profile
Tiffany Abode
NPI 1184234445
$1,952.82
in general payments reported to CMS, 2019-2025
27 companies · $1,133 in 2025
The $1,133 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.17 · 2022: $78.23 · 2023: $367 · 2024: $316 · 2025: $1,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,347 · Travel and Lodging: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,346.76 |
| Travel and Lodging | $469.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $469.66 | 2025 | Barostim Neo System |
| Boston Scientific Corporation | $198.11 | 2021-2025 | General - Crm_crm |
| Edwards Lifesciences Corporation | $190.11 | 2025 | Pascal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $186.58 | 2023 | Lifevest |
| Alnylam Pharmaceuticals INC. | $125.00 | 2025 | Amvuttra |
| Kestra Medical Technology Services, INC. | $101.08 | 2024 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $100.58 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Silk Road Medical, INC. | $78.40 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| United Therapeutics Corporation | $71.69 | 2024-2025 | Tyvaso, Tyvaso |
| Imperative Care, INC | $69.54 | 2025 | Prodigy Catheter, Symphony Catheter, Prodigy Twist |
| Janssen Pharmaceuticals, INC | $62.37 | 2024 | Xarelto |
| Angiodynamics, INC. | $41.61 | 2023 | Auryon Laser System 100-120 Vac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.63 | 2024-2025 | Jardiance |
| Chiesi USA, INC. | $21.72 | 2025 | Juxtapid |
| Atricure, INC. | $18.83 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18.09 | 2024 | Micra |
| Biogen, INC. | $17.08 | 2024 | Skyclarys |
| Tactile Systems Technology INC | $16.99 | 2023 | Flexitouch Plus, Entre Plus |
| Scpharmaceuticals INC. | $16.99 | 2025 | |
| Agepha Pharma Fz LLC | $15.36 | 2025 | Lodoco |
| Merck Sharp & Dohme LLC | $15.24 | 2023 | Verquvo |
| Amarin Pharma, INC. | $14.93 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.48 | 2022 | |
| Abiomed | $13.90 | 2025 | |
| Exeltis, USA INC. | $13.58 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $13.53 | 2023 | Arcalyst |
| Abbvie INC. | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Abode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.